Ingrezza® (valbenazine)
| Full Name | Ingrezza® (valbenazine) |
| Drug | Ingrezza |
| Manufacturer | Neurocrine Biosciences |
| Route of Administration | Oral |
| Site of Care | Home |
| Approved Indication | The treatment of adults with tardive dyskinesia or chorea associated with Huntington’s disease |
| Disease | Tardive Dyskinesia (TD); Huntington’s Disease Chorea |
| Therapeutic Area | Psychiatry, Neurology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-279-1676 |
| Fax Number | 877-868-1681 |
| Product Website | ingrezzahcp.com |